跳至主要内容
临床试验/NL-OMON33986
NL-OMON33986已完成不适用

Medication induced blood pressure reduction; assessment of cerebral perfusion and cognition in hypertensive elderly - MBRACE

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Systolic hypertension grade II-III ( Systolic BP >=160mmHg) as measured according to JNC-7 protocol

排除标准

  • Systolic blood pressure >220mmHg
  • Indication for urgent treatment of HT
  • Contra-indication for MRI including claustrophobia
  • Contra-indication for anti-hypertensive medication used (Chlorthalidone, Amlodipine, Valsartan)
  • Renal failure requiring dialysis
  • Atrial fibrillation
  • A life expectancy of less than a year
  • Disabling stroke
  • Impairment by any cause prohibiting participation as mentioned by the general practitioner
  • Diabetes Mellitus

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验